Published in J Clin Oncol on July 01, 2000
Complementary and alternative medicine use among long-term lymphoma survivors: a pilot study. Am J Hematol (2009) 2.84
Trends in complementary/alternative medicine use by breast cancer survivors: comparing survey data from 1998 and 2005. BMC Womens Health (2007) 2.24
Clinical practice guidelines on the use of integrative therapies as supportive care in patients treated for breast cancer. J Natl Cancer Inst Monogr (2014) 2.13
The prevalence, patterns of usage and people's attitude towards complementary and alternative medicine (CAM) among the Indian community in Chatsworth, South Africa. BMC Complement Altern Med (2004) 1.96
The use of complementary and alternative medicine among california adults with and without cancer. Evid Based Complement Alternat Med (2005) 1.82
Prevalence of complementary and alternative medicine use in cancer patients during treatment. Support Care Cancer (2005) 1.76
Use of complementary/alternative therapies by women with advanced-stage breast cancer. BMC Complement Altern Med (2002) 1.74
Complementary and alternative medicines use by Scottish women with breast cancer. What, why and the potential for drug interactions? Eur J Clin Pharmacol (2011) 1.62
Preservation of immune function in cervical cancer patients during chemoradiation using a novel integrative approach. Brain Behav Immun (2010) 1.61
Practice patterns of naturopathic physicians: results from a random survey of licensed practitioners in two US States. BMC Complement Altern Med (2004) 1.54
Cancer patient disclosure and patient-doctor communication of complementary and alternative medicine use: a systematic review. Oncologist (2012) 1.34
Complementary and alternative medicine use in breast cancer patients in Europe. Support Care Cancer (2005) 1.33
Potential of chemotherapy-herb interactions in adult cancer patients. Support Care Cancer (2004) 1.31
The use of complementary and alternative medicines among patients with locally advanced breast cancer--a descriptive study. BMC Cancer (2006) 1.30
Discrepant views of oncologists and cancer patients on complementary/alternative medicine. Support Care Cancer (2004) 1.25
Bridging the gap: decision-making processes of women with breast cancer using complementary and alternative medicine (CAM). Support Care Cancer (2007) 1.20
Discussing complementary therapies with cancer patients: what should we be talking about? J Clin Oncol (2000) 1.16
Use of complementary and alternative medicine by patients with breast cancer: observations from a health-care survey. Support Care Cancer (2004) 1.12
Physical distress and cancer care experiences among Chinese-American and non-Hispanic White breast cancer survivors. Gynecol Oncol (2011) 1.09
Prevalence and predictors of antioxidant supplement use during breast cancer treatment: the Long Island Breast Cancer Study Project. Cancer (2009) 1.07
ECA39 is a novel distant metastasis-related biomarker in colorectal cancer. World J Gastroenterol (2006) 1.07
Presenting the alternative: cancer and complementary and alternative medicine in the Canadian print media. Support Care Cancer (2007) 1.01
Public awareness, patterns of use and attitudes toward natural health products in Kuwait: a cross-sectional survey. BMC Complement Altern Med (2014) 1.00
Practices, attitudes, and beliefs associated with complementary and alternative medicine (CAM) use among cancer patients. Integr Cancer Ther (2012) 0.99
Investigation on Semecarpus Lehyam--a Siddha medicine for breast cancer. Planta (2004) 0.99
Increased health care utilisation among 10-year breast cancer survivors. Support Care Cancer (2006) 0.97
The use of dietary supplements in a community hospital comprehensive cancer center: implications for conventional cancer care. Support Care Cancer (2005) 0.96
The use of Complementary and Alternative Medicine by cancer patients. Int Semin Surg Oncol (2007) 0.95
Talking to cancer patients about complementary therapies: is it the physician's responsibility? Curr Oncol (2008) 0.95
The status of complementary therapy services in Canadian palliative care settings. Support Care Cancer (2007) 0.92
Complementary and alternative medicine use and assessment of quality of life in Korean breast cancer patients: a descriptive study. Support Care Cancer (2011) 0.92
Practitioners' sources of clinical information on complementary and alternative medicine in oncology. Support Care Cancer (2003) 0.91
Complementary and Alternative Medicine Use among Norwegian Cancer Survivors: Gender-Specific Prevalence and Associations for Use. Evid Based Complement Alternat Med (2013) 0.91
How oncologists discuss complementary therapy use with their patients: an audio-tape audit. Support Care Cancer (2003) 0.90
Dual-mode interaction between quercetin and DNA-damaging drugs in cancer cells. Anticancer Res (2012) 0.90
Prevalence and predictors of complementary therapy use in advanced-stage breast cancer patients. J Oncol Pract (2007) 0.88
Estrogenic botanical supplements, health-related quality of life, fatigue, and hormone-related symptoms in breast cancer survivors: a HEAL study report. BMC Complement Altern Med (2011) 0.88
Familial and perceived risk of breast cancer in relation to use of complementary medicine. Cancer Epidemiol Biomarkers Prev (2008) 0.87
Predictors of yoga use among patients with breast cancer. Explore (NY) (2010) 0.85
The herb medicine formula "chong lou fu fang" increases the cytotoxicity of chemotherapeutic agents and down-regulates the expression of chemotherapeutic agent resistance-related genes in human gastric cancer cells in vitro. Evid Based Complement Alternat Med (2011) 0.85
Any difference? Use of a CAM provider among cancer patients, coronary heart disease (CHD) patients and individuals with no cancer/CHD. BMC Complement Altern Med (2012) 0.84
Dietary supplement use in adult cancer survivors. Oncol Nurs Forum (2009) 0.82
National survey of US oncologists' knowledge, attitudes, and practice patterns regarding herb and supplement use by patients with cancer. J Clin Oncol (2014) 0.82
Anticancer effect of jinlongshe granules on in situ-transplanted human MKN-45 gastric cancer in nude mice and xenografted sarcoma 180 in Kunming mice and its mechanism. World J Gastroenterol (2006) 0.82
Dietary supplement use among elderly, long-term cancer survivors. J Cancer Surviv (2008) 0.81
Black cohosh (Cimicifuga racemosa [L.] Nutt.): safety and efficacy for cancer patients. Support Care Cancer (2007) 0.81
Complementary and alternative medicine use and quality of life in pediatric diabetes. J Altern Complement Med (2010) 0.81
Patients in Northwestern Turkey Prefer Herbs as Complementary Medicine after Breast Cancer Diagnosis. Breast Care (Basel) (2008) 0.80
The effect of spiritual healing on in vitro tumour cell proliferation and viability--an experimental study. Br J Cancer (2005) 0.80
Effect of soy isoflavones on the growth of human breast tumors: findings from preclinical studies. Food Sci Nutr (2014) 0.80
Going against the Herd: Psychological and Cultural Factors Underlying the 'Vaccination Confidence Gap'. PLoS One (2015) 0.80
Complementary therapies in cancer patients: prevalence and patients' motives. Wien Klin Wochenschr (2003) 0.79
Self-reported quality of life in users and nonusers of dietary supplements in cancer. Support Care Cancer (2005) 0.79
The truth-telling issue and changes in lifestyle in patients with cancer. J Med Ethics (2006) 0.79
Does perceived control predict Complementary and Alternative Medicine (CAM) use among patients with lung cancer? A cross-sectional survey. Support Care Cancer (2014) 0.79
Cancer and complementary medicine: an international perspective. Support Care Cancer (2007) 0.78
Reasons to Use and Disclose Use of Complementary Medicine Use - An Insight from Cancer Patients. Cancer Clin Oncol (2013) 0.78
Effective communication about the use of complementary and integrative medicine in cancer care. J Altern Complement Med (2013) 0.78
The Use of Complementary and Alternative Medicine by Korean Breast Cancer Women: Is It Associated with Severity of Symptoms? Evid Based Complement Alternat Med (2015) 0.78
Complementary and Integrative Health Practices Among Hispanics Diagnosed with Colorectal Cancer: Utilization and Communication with Physicians. J Altern Complement Med (2016) 0.78
Opinions on chelation therapy in patients undergoing coronary angiography: cross-sectional survey. Can J Cardiol (2007) 0.77
Safety and Efficacy of Tien-Hsien Liquid Practical in Patients with Refractory Metastatic Breast Cancer: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase IIa Trial. Evid Based Complement Alternat Med (2012) 0.77
Development and Validation of an Instrument for Measuring Attitudes and Beliefs about Complementary and Alternative Medicine (CAM) Use among Cancer Patients. Evid Based Complement Alternat Med (2012) 0.76
In vitro screening of tumoricidal properties of international medicinal herbs: part II. Phytother Res (2010) 0.76
The roles of herbal remedies in survival and quality of life among long-term breast cancer survivors--results of a prospective study. BMC Cancer (2011) 0.76
Making sense of "alternative", "complementary", "unconventional" and "integrative" medicine: exploring the terms and meanings through a textual analysis. BMC Complement Altern Med (2016) 0.76
Complementary therapies in cancer patients. J Clin Oncol (2001) 0.75
Complementary and Alternative Medicine Use and Its Association with Emotional Status and Quality of Life in Patients with a Solid Tumor: A Cross-Sectional Study. J Altern Complement Med (2017) 0.75
Crude aqueous extracts of Pluchea indica (L.) Less. inhibit proliferation and migration of cancer cells through induction of p53-dependent cell death. BMC Complement Altern Med (2012) 0.75
National survey of China's oncologists' knowledge, attitudes, and clinical practice patterns on complementary and alternative medicine. Oncotarget (2017) 0.75
Use of dietary supplements by breast cancer patients undergoing conventional cancer treatment. Patient Prefer Adherence (2010) 0.75
Measuring perceived effects of drinking an extract of basidiomycetes Agaricus blazei Murill: a survey of Japanese consumers with cancer. BMC Complement Altern Med (2007) 0.75
Predictors of chronic cerebrospinal venous insufficiency procedure use among older people with multiple sclerosis: a national case-control study. BMC Health Serv Res (2015) 0.75
Complementary medicine use among Moroccan patients with cancer: a descriptive study. Pan Afr Med J (2011) 0.75
Use of complementary and alternative medicines among Malaysian cancer patients: A descriptive study. J Tradit Complement Med (2015) 0.75
Use of non-conventional medicine two years after cancer diagnosis in France: evidence from the VICAN survey. J Cancer Surviv (2017) 0.75
Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet (2005) 24.57
Mortality in relation to smoking: 40 years' observations on male British doctors. BMJ (1994) 23.80
The impact of patient-centered care on outcomes. J Fam Pract (2000) 15.07
Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials. Lancet (2011) 10.62
Long-term donepezil treatment in 565 patients with Alzheimer's disease (AD2000): randomised double-blind trial. Lancet (2004) 9.10
Doctor-patient communication: the Toronto consensus statement. BMJ (1991) 8.57
Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials. Lancet (2011) 8.24
Towards a global definition of patient centred care. BMJ (2001) 7.60
Communication patterns of primary care physicians. JAMA (1997) 6.88
Randomised trial of prophylactic daily aspirin in British male doctors. Br Med J (Clin Res Ed) (1988) 6.76
Mortality in relation to consumption of alcohol: 13 years' observations on male British doctors. BMJ (1994) 6.74
The patient-centred clinical method. 1. A model for the doctor-patient interaction in family medicine. Fam Pract (1986) 5.95
Mortality in relation to smoking: 22 years' observations on female British doctors. Br Med J (1980) 5.21
Attitudes and patterns of practice: a comparison of graduates of a residency program in family medicine and controls. J Fam Pract (1978) 5.09
Annual hazard rates of recurrence for breast cancer after primary therapy. J Clin Oncol (1996) 4.92
Tropomyosin coiled-coil interactions: evidence for an unstaggered structure. J Mol Biol (1975) 4.79
Breast cancer survival by teaching status of the initial treating hospital. CMAJ (2001) 4.75
Patient-centredness in the consultation. 2: Does it really make a difference? Fam Pract (1990) 4.40
Control of sexually transmitted diseases for HIV-1 prevention: understanding the implications of the Mwanza and Rakai trials. Lancet (2000) 4.39
EPITHELIAL HEALING AND THE TRANSPLANTATION OF SKIN. Ann Surg (1942) 4.23
Evidence on patient-doctor communication. Cancer Prev Control (1999) 4.17
The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hand. Arthritis Rheum (1990) 3.97
Human endothelial actin-binding protein (ABP-280, nonmuscle filamin): a molecular leaf spring. J Cell Biol (1990) 3.76
Patterns of initial management of node-negative breast cancer in two Canadian provinces. British Columbia/Ontario Working Group. CMAJ (1997) 3.74
Large-scale randomized evidence: large, simple trials and overviews of trials. J Clin Epidemiol (1995) 3.51
Cell membrane dynamics and insulin resistance in non-insulin-dependent diabetes mellitus. Lancet (1995) 3.33
Structural basis for the interaction between FxFG nucleoporin repeats and importin-beta in nuclear trafficking. Cell (2000) 3.33
Systematic review of effects of low-moderate prenatal alcohol exposure on pregnancy outcome. BJOG (2007) 3.31
HIV incidence and sexually transmitted disease prevalence associated with condom use: a population study in Rakai, Uganda. AIDS (2001) 3.30
Cancer prevalence in the United Kingdom: estimates for 2008. Br J Cancer (2009) 3.27
A CUTANEOUS TEST FOR TUBERCULOSIS IN PRIMATES. Science (1939) 3.25
The 14-fold periodicity in alpha-tropomyosin and the interaction with actin. J Mol Biol (1976) 3.23
Adjuvant chemotherapy in oestrogen-receptor-poor breast cancer: patient-level meta-analysis of randomised trials. Lancet (2008) 2.91
Physiological basis of motor effects of a transient stimulus to cerebral cortex. Neurosurgery (1987) 2.88
THE UTILIZATION OF THE TEMPORAL MUSCLE AND FASCIA IN FACIAL PARALYSIS. Ann Surg (1939) 2.85
The patient-centred clinical method. 2. Definition and application. Fam Pract (1986) 2.83
NTF2 mediates nuclear import of Ran. EMBO J (1998) 2.79
Increased mortality of women in coronary artery bypass surgery: evidence for referral bias. Ann Intern Med (1990) 2.75
Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials. Lancet (2015) 2.70
A systematic review of studies validating the Edinburgh Postnatal Depression Scale in antepartum and postpartum women. Acta Psychiatr Scand (2009) 2.68
Consensus criteria for the classification of carpal tunnel syndrome in epidemiologic studies. Am J Public Health (1998) 2.53
The St. Jude valve. Thrombolysis as the first line of therapy for cardiac valve thrombosis. Circulation (1993) 2.51
A comparison of corticospinal activation by magnetic coil and electrical stimulation of monkey motor cortex. Electroencephalogr Clin Neurophysiol (1990) 2.51
The Nithsdale schizophrenia surveys. VIII: Do relatives want family intervention--and does it help? Br J Psychiatry (1991) 2.48
Parental and professional perception of need for emergency admission to hospital: prospective questionnaire based study. Arch Dis Child (1998) 2.45
Domain assignment for protein structures using a consensus approach: characterization and analysis. Protein Sci (1998) 2.41
Treatment of attentional and hyperactivity problems in children with sympathomimetic drugs: a comprehensive review. J Am Acad Child Adolesc Psychiatry (1990) 2.36
Leukemogenic potential of adjuvant chemotherapy for early-stage breast cancer: the Eastern Cooperative Oncology Group experience. J Clin Oncol (1995) 2.33
Cerebral oxygen metabolism during hypothermic circulatory arrest in humans. J Neurosurg (1993) 2.33
Urinary OEstrogen Metabolites of 19-Norethisterone and its Esters [Summary]. Proc R Soc Med (1960) 2.29
How to obtain excellent response rates when surveying physicians. Fam Pract (2008) 2.26
Postchemotherapy adjuvant tamoxifen therapy beyond five years in patients with lymph node-positive breast cancer. Eastern Cooperative Oncology Group. J Natl Cancer Inst (1996) 2.25
Locoregional failure 10 years after mastectomy and adjuvant chemotherapy with or without tamoxifen without irradiation: experience of the Eastern Cooperative Oncology Group. J Clin Oncol (1999) 2.22
Alzheimer's disease, other dementias, depression and pseudodementia: prevalence, incidence and three-year outcome in Liverpool. Br J Psychiatry (1992) 2.20
Global expression changes of constitutive and hormonally regulated genes during endometrial neoplastic transformation. Gynecol Oncol (2001) 2.20
Thresholds for treatment in cataract surgery. J Public Health Med (1994) 2.12
Large-scale randomized evidence: large, simple trials and overviews of trials. Ann N Y Acad Sci (1993) 2.08
Subunit structure of paired helical filaments in Alzheimer's disease. J Cell Biol (1985) 2.06
Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials. Lancet (2015) 2.05
Cognitive planning deficit in patients with cerebellar atrophy. Neurology (1992) 2.03
A new inexpensive pump for vitreoretinal surgery. Arch Ophthalmol (1991) 2.02
Range of mental illness among the elderly in the community. Prevalence in Liverpool using the GMS-AGECAT package. Br J Psychiatry (1987) 1.96
Changing face of family practice. Can Fam Physician (1998) 1.96
Congestive heart failure in type 2 diabetes: prevalence, incidence, and risk factors. Diabetes Care (2001) 1.95
The patient-centred clinical method. 3. Changes in residents' performance over two months of training. Fam Pract (1986) 1.93
National study of colorectal cancer genetics. Br J Cancer (2007) 1.92
Patients, friends, and relationship boundaries. Can Fam Physician (1993) 1.92
Effects on 4080 rats of chronic ingestion of N-nitrosodiethylamine or N-nitrosodimethylamine: a detailed dose-response study. Cancer Res (1991) 1.92
Vitamin D metabolism: the role of kidney tissue. Science (1971) 1.91
Induction of ovulation. J Obstet Gynaecol Br Commonw (1966) 1.91
Venous and arterial thrombosis in patients who received adjuvant therapy for breast cancer. J Clin Oncol (1991) 1.91
Patient-centred interviewing part I: understanding patients' experiences. Can Fam Physician (1989) 1.89
Post-traumatic parotid fistulae and sialoceles. A prospective study of conservative management in 51 cases. Ann Surg (1989) 1.89
Treatment of Metastatic Carcinoma of the Neck. Ann Surg (1944) 1.89
Patient-Centred Interviewing Part III: Five Provocative Questions. Can Fam Physician (1989) 1.89
Virus-encoded serine proteinase inhibitor SERP-1 inhibits atherosclerotic plaque development after balloon angioplasty. Circulation (1996) 1.86
Patient-physician communication assessment instruments: 1986 to 1996 in review. Patient Educ Couns (1998) 1.82
The recovery and preliminary characterization of X chromosome mutants affecting imaginal discs of Drosophila melanogaster. Dev Biol (1972) 1.80
Decision aids: are they worth it? A systematic review. J Health Serv Res Policy (2001) 1.78
Interaction between NTF2 and xFxFG-containing nucleoporins is required to mediate nuclear import of RanGDP. J Mol Biol (1999) 1.77
Systematic review of patient and nurse attitudes to depot antipsychotic medication. Br J Psychiatry (2001) 1.75
Perinatal autopsy: its clinical value. Obstet Gynecol (1986) 1.74
Measuring quality of life among HIV-infected women using a culturally adapted questionnaire in Rakai district, Uganda. AIDS Care (2004) 1.74
The Repair of Surface Defects of the Foot. Ann Surg (1944) 1.73
Efficacy of adjuvant chemotherapy in high-risk node-negative breast cancer. An intergroup study. N Engl J Med (1989) 1.70
Acute effects of inhaled urban particles and ozone: lung morphology, macrophage activity, and plasma endothelin-1. Am J Pathol (1998) 1.70
State health expenditure accounts: building blocks for state health spending analysis. Health Care Financ Rev (1995) 1.70
MASSIVE REPAIRS OF BURNS WITH THICK SPLIT-SKIN GRAFTS: EMERGENCY "DRESSINGS" WITH HOMOGRAFTS. Ann Surg (1942) 1.68
Predictors of glycemic control in insulin-using adults with type 2 diabetes. Diabetes Care (2000) 1.68
Behavioural, physiological and morphological analysis of a line of apolipoprotein E knockout mouse. Neuroscience (1998) 1.68
Transverse-momentum and pseudorapidity distributions of charged hadrons in pp collisions at square root of s = 7 TeV. Phys Rev Lett (2010) 1.67
Pathway of incorporation of microinjected lamin A into the nuclear envelope. J Cell Biol (1992) 1.66
Randomised trials of STD treatment for HIV prevention: report of an international workshop. HIV/STD Trials Workshop Group. Genitourin Med (1997) 1.66
Perceptual correlates of massive cortical reorganization. Science (1992) 1.65
Immunology: Toll-like receptors and antibody responses. Nature (2006) 1.64